Literature DB >> 3479818

Effective sample sizes for confidence intervals for survival probabilities.

F J Dorey1, E L Korn.   

Abstract

We examine various methods to estimate the effective sample size for construction of confidence intervals for survival probabilities. We compare the effective sample sizes of Cutler and Ederer and Peto et al., as well as a modified Cutler-Ederer effective sample size. We investigate the use of these effective sample sizes in the common situation of many censored observations that intervene between the time point of interest and the last death before this time. We note that there is no a priori reason to treat upper and lower confidence intervals in a symmetric fashion since censored survival data are by nature asymmetric. We recommend the use of the Cutler-Ederer effective sample size in construction of upper confidence intervals and the Peto effective sample size in construction of lower confidence intervals. Two examples with real data demonstrate the differences between confidence intervals formed with different effective sample sizes. This study also illustrates the need for caution in the application of simulation studies to real problems.

Mesh:

Year:  1987        PMID: 3479818     DOI: 10.1002/sim.4780060605

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  [The cemented MS-30 stem. A multi-surgeon series of 333 consecutive cases].

Authors:  M Clauss; T Reitzel; M Pritsch; U J Schlegel; R G Bitsch; V Ewerbeck; H Mau; S J Breusch
Journal:  Orthopade       Date:  2006-07       Impact factor: 1.087

2.  Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database.

Authors:  Emmanuel S Antonarakis; Yongmei Chen; Sally I Elsamanoudi; Stephen A Brassell; Mario V Da Rocha; Mario A Eisenberger; David G McLeod
Journal:  BJU Int       Date:  2010-11-23       Impact factor: 5.588

3.  Pointwise confidence intervals for a survival distribution with small samples or heavy censoring.

Authors:  Michael P Fay; Erica H Brittain; Michael A Proschan
Journal:  Biostatistics       Date:  2013-04-30       Impact factor: 5.899

Review 4.  Clinical Benefit Scales and Trial Design: Some Statistical Issues.

Authors:  Edward L Korn; Carmen J Allegra; Boris Freidlin
Journal:  J Natl Cancer Inst       Date:  2022-09-09       Impact factor: 11.816

5.  [Acetabular reinforcement rings in revision total hip arthroplasty: midterm results in 298 cases].

Authors:  U J Schlegel; R G Bitsch; M Pritsch; P R Aldinger; H Mau; S J Breusch
Journal:  Orthopade       Date:  2008-09       Impact factor: 1.087

6.  Analysis of the genotype and virulence of Staphylococcus epidermidis isolates from patients with infective endocarditis.

Authors:  Alastair B Monk; Sam Boundy; Vivian H Chu; Jill C Bettinger; Jaime R Robles; Vance G Fowler; Gordon L Archer
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

7.  THA using metal-on-metal articulation in active patients younger than 50 years.

Authors:  Christian P Delaunay; François Bonnomet; Philippe Clavert; Philippe Laffargue; Henri Migaud
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

8.  Statistical analysis of arthroplasty data. I. Introduction and background.

Authors:  Jonas Ranstam; Johan Kärrholm; Pekka Pulkkinen; Keijo Mäkelä; Birgitte Espehaug; Alma Becic Pedersen; Frank Mehnert; Ove Furnes
Journal:  Acta Orthop       Date:  2011-06       Impact factor: 3.717

9.  Results of 189 wrist replacements. A report from the Norwegian Arthroplasty Register.

Authors:  Yngvar Krukhaug; Stein A Lie; Leif I Havelin; Ove Furnes; Leiv M Hove
Journal:  Acta Orthop       Date:  2011-06-10       Impact factor: 3.717

10.  Prognostic impact of chromosomal aberrations in Ewing tumours.

Authors:  C M Hattinger; U Pötschger; M Tarkkanen; J Squire; M Zielenska; S Kiuru-Kuhlefelt; L Kager; P Thorner; S Knuutila; F K Niggli; P F Ambros; H Gadner; D R Betts
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.